The epidemiology of human papillomavirus infections

af Geijersstam, 1998, Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969–1989, Int J Cancer, 76, 341, 10.1002/(SICI)1097-0215(19980504)76:3<341::AID-IJC10>3.0.CO;2-E Bachtiary, 2002, Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer, Int J Cancer, 102, 237, 10.1002/ijc.10708 Bauer, 1993, Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon, Sex Transm Dis, 20, 274, 10.1097/00007435-199309000-00007 Becker, 1987, Genital human papillomavirus infection. A growing concern, Obstet Gynecol Clin North Am, 14, 389, 10.1016/S0889-8545(21)00062-0 Berumen, 2001, Asian–American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study, J Natl Cancer Inst, 93, 1325, 10.1093/jnci/93.17.1325 Bosch, 2003, Chapter 1: human papillomavirus and cervical cancer—burden and assessment of causality, J Natl Cancer Inst Monogr, 3, 10.1093/oxfordjournals.jncimonographs.a003479 Brown, 2001, Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer, J Infect Dis, 184, 1183, 10.1086/323645 Burk, 1996, Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women, J Infect Dis, 174, 679, 10.1093/infdis/174.4.679 Carter, 2000, Comparison of human papillomavirus types 16, 18 and 6 capsid antibody responses following incident infection, J Infect Dis, 181, 1911, 10.1086/315498 Carter, 1996, The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women, J. Infect. Dis., 174, 927, 10.1093/infdis/174.5.927 Chuang, 1984, Condyloma acuminatum in Rochester, MI, 1950–1978. I. Epidemiology and clinical features, Arch Dermatol, 120, 469, 10.1001/archderm.120.4.469 Clark, 2004, Cancer of the anal canal, Lancet Oncol, 5, 149, 10.1016/S1470-2045(04)01410-X Cohen, 2003, Beyond slogans: lessons from Uganda's experience with ABC and HIV/AIDS Cuschieri, 2004, Multiple high-risk HPV infections are common in cervical neoplasia and young women in a cervical screening population, J Clin Pathol, 57, 68, 10.1136/jcp.57.1.68 Cuschieri, 2004, Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring, J Med Virol, 73, 65, 10.1002/jmv.20062 Daling, 2002, A population-based study of squamous cell vaginal cancer: HPV and cofactors, Gynecol Oncol, 84, 263, 10.1006/gyno.2001.6502 Davidson, 1994, The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska native women, J Infect Dis, 169, 792, 10.1093/infdis/169.4.792 Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 Einstein, 2002, Human papillomavirus and cervical neoplasia, Cancer Invest, 20, 1080, 10.1081/CNV-120005927 Emeny, 2002, Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine, J Virol, 76, 7832, 10.1128/JVI.76.15.7832-7842.2002 Evander, 1995, Human papillomavirus infection is transient in young women: a population-based cohort study, J Infect Dis, 171, 1026, 10.1093/infdis/171.4.1026 Evans, 2001, A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers, J Infect Dis, 183, 1485, 10.1086/320190 Franceschi, 2002, Prevalence and determinants of human papillomavirus genital infection in men, Br J Cancer, 86, 705, 10.1038/sj.bjc.6600194 Franco, 1999, Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer, J Infect Dis, 180, 1415, 10.1086/315086 Gillison, 2004, A causal role for human papillomavirus in head and neck cancer, Lancet, 363, 1488, 10.1016/S0140-6736(04)16194-1 Giuliano, 2002, Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study, J Infect Dis, 186, 462, 10.1086/341782 Goldie, 2004, Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine, J Natl Cancer Inst, 96, 604, 10.1093/jnci/djh104 Greer, 1995, Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts, J Clin Microbiol, 33, 2058, 10.1128/JCM.33.8.2058-2063.1995 Harris, 2004, Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia, Am J Epidemiol, 159, 834, 10.1093/aje/kwh115 Harro, 2001, Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine, J Natl Cancer Inst, 93, 284, 10.1093/jnci/93.4.284 Herrero, 2000, Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica, J Natl Cancer Inst, 92, 464, 10.1093/jnci/92.6.464 Hildesheim, 2001, HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica, Br J Cancer, 84, 1219, 10.1054/bjoc.2001.1779 Hildesheim, 1994, Persistence of type-specific human papillomavirus infection among cytologically normal women, J Infect Dis, 169, 235, 10.1093/infdis/169.2.235 Hinchliffe, 1995, Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology, Br J Cancer, 72, 943, 10.1038/bjc.1995.438 Hippelainen, 1993, Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts, Sex Transm Dis, 20, 321, 10.1097/00007435-199320060-00004 Ho, 1998, Natural history of cervicovaginal papillomavirus infection in young women, N Engl J Med, 338, 423, 10.1056/NEJM199802123380703 Ho, 2004, Natural history of human papillomavirus type 16 virus-like particle antibodies in young women, Cancer Epidemiol. Biomarkers Prev., 13, 110, 10.1158/1055-9965.EPI-03-0191 IARC (International Agency for Research on Cancer). Monograph on the evaluation of carcinogenic risks to humans, vol 64. Human papillomaviruses. Lyon: IARC, 1995. Jeon, 1995, Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis, Proc Natl Acad Sci USA, 92, 1654, 10.1073/pnas.92.5.1654 Jones, 1999, Cancer in the developing world: a call to action, BMJ, 319, 505, 10.1136/bmj.319.7208.505 Karlsson, 1995, Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study, Sex Transm Dis, 22, 119, 10.1097/00007435-199503000-00008 Kinlen, 1978, Women with positive cervical smears but without surgical intervention. A follow-up study, Lancet, 2, 463, 10.1016/S0140-6736(78)91457-5 Kirnbauer, 1992, Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic, Proc Natl Acad Sci USA, 89, 12180, 10.1073/pnas.89.24.12180 Koutsky, 2002, A controlled trial of a human papillomavirus type 16 vaccine, N Engl J Med, 347, 1645, 10.1056/NEJMoa020586 Koutsky, 1992, A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection, N Engl J Med, 327, 1272, 10.1056/NEJM199210293271804 Kulasingam, 2002, Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral, JAMA, 288, 1749, 10.1001/jama.288.14.1749 Kulasingam, 2003, Potential health and economic impact of adding a human papillomavirus vaccine to screening programs, JAMA, 290, 781, 10.1001/jama.290.6.781 Laukkanen, 2003, Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland, J Gen Virol, 84, 2105, 10.1099/vir.0.18995-0 Ley, 1991, Determinants of genital human papillomavirus infection in young women, J Natl Cancer Inst, 83, 997, 10.1093/jnci/83.14.997 Liaw, 1999, Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions, J Natl Cancer Inst, 91, 954, 10.1093/jnci/91.11.954 Liaw, 2001, A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types, J Infect Dis, 183, 8, 10.1086/317638 Manhart, 2002, Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis, Sex Transm Dis, 29, 725, 10.1097/00007435-200211000-00018 Moreno, 2002, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3 Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641 Munoz, 2002, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet, 359, 1093, 10.1016/S0140-6736(02)08151-5 Negrini, 1990, Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix, Cancer Res, 50, 4670 Pecorelli, 2003, Cancer in women, Int J Gynaecol Obstet, 82, 369, 10.1016/S0020-7292(03)00225-X Petersen, 1956, Spontaneous course of cervical precancerous conditions, Am J Obstet Gynecol, 72, 1063, 10.1016/0002-9378(56)90072-2 Richardson, 2003, The natural history of type-specific human papillomavirus infections in female university students, Cancer Epidemiol Biomarkers Prev, 12, 485 Ries, 2004 Rohan, 1991, PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer, Int J Cancer, 49, 856, 10.1002/ijc.2910490609 Rousseau, 2001, Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection, J Infect Dis, 184, 1508, 10.1086/324579 Rubin, 2001, Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis, Am J Pathol, 159, 1211, 10.1016/S0002-9440(10)62506-0 Schiffman, 1992, Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia, J Natl Cancer Inst, 84, 394, 10.1093/jnci/84.6.394 Smith, 2002, Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines, J Infect Dis, 185, 324, 10.1086/338569 Steenbergen R, de Wilde J, Wilting SM, Brink AATP, Snijders PJF, Meijer CJLM. HPV-mediated transformation of the anogenital tract. J Clin Virol, this volume. Stern PL,, 2005. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J Clin Virol, this volume. Stone, 2002, Seroprevalence of human papillomavirus type 16 infection in the United States, J Infect Dis, 186, 1396, 10.1086/344354 Svare, 2002, Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic, Sex Transm Infect, 78, 215, 10.1136/sti.78.3.215 Tarkowski, 2004, Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population, J Infect Dis, 189, 46, 10.1086/380466 Tornesello, 2004, Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer, J Med Virol, 74, 117, 10.1002/jmv.20154 Trimble, 1996, Heterogeneous etiology of squamous carcinoma of the vulva, Obstet Gynecol, 87, 59, 10.1016/0029-7844(95)00351-7 van der Graaf, 2002, Human papillomavirus and the long-term risk of cervical neoplasia, Am. J. Epidemiol., 156, 158, 10.1093/aje/kwf013 Vernon, 1994, A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women, J Infect Dis, 169, 1108, 10.1093/infdis/169.5.1108 Wang, 2003, Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10,000 women in Costa Rica, Br J Cancer, 89, 1248, 10.1038/sj.bjc.6601272 Weaver, 2004, Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men, J Infect Dis, 189, 677, 10.1086/381395 Wheeler, 1993, Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center, Sex Transm Dis, 20, 286, 10.1097/00007435-199309000-00009 Winer, 2003, Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students, Am J Epidemiol, 157, 218, 10.1093/aje/kwf180 Woodman, 2001, Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study, Lancet, 357, 1831, 10.1016/S0140-6736(00)04956-4 Xi, 1995, Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection, J Infect Dis, 172, 747, 10.1093/infdis/172.3.747 Xi, 1997, Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia, J Natl Cancer Inst, 89, 796, 10.1093/jnci/89.11.796 zur Hausen, 1996, Roots and perspectives of contemporary papillomavirus research, J. Cancer Res. Clin. Oncol., 122, 3, 10.1007/BF01203067 Zhou, 1991, Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles, Virology, 185, 251, 10.1016/0042-6822(91)90772-4